Генетическая карта здоровья (стр. 7 )

15. Riancho, J. A., et al., Common Variations In Estrogen-Related Genes Are Associated With Severe Large Joint Osteoarthritis: A Multicenter Genetic And Functional Study. Osteoarthritis Cartilage, 2010.

16. Терещенко, С. Н., et al., Полиморфизм генов ангиотензинпревращающего фермента, ангиотензина II, NO-синтетазы, эстрогеновых рецепторов и гендерные различия в их влиянии на развитие сердечно-сосудистой патологии, in Кардиология. 2009. p. 58-62.

17. Tobias, J. H., et al., Estrogen receptor alpha regulates area-adjusted bone mineral content in late pubertal girls. J Clin Endocrinol Metab, 2007. 92(2): p. 641-7.

18. Taguchi, A., et al., Association of estrogen and vitamin D receptor gene polymorphisms with tooth loss and oral bone loss in Japanese postmenopausal women. Menopause, 2003. 10(3): p. 250-7.

19. Molvarec, A., et al., Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res, 2007. 30(3): p. 205-11.

20. Matsuoka, N., et al., Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Clin Exp Immunol, 1996. 104(3): p. 501-8.

21. Morikawa, K., et al., Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother, 1996. 40(6): p. 1366-70.

22. Yoshimura, T., et al., Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines. Biol Pharm Bull, 1995. 18(6): p. 876-81.

23. Nikolopoulos, G. K., et al., Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol, 2008.

24. Mattuzzi, S., et al., Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol, 2007. 34(5): p. 997-1004.

25. Trevilatto, P. C., et al., Association of IL1 gene polymorphisms with chronic periodontitis in Brazilians. Arch Oral Biol, 2010.

26. Barrett, J. C., et al., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 2005. 21(2): p. 263-5.

27. Walker, W. G., et al., Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension, 1979. 1(3): p. 287-91.

28. Sethi, A. A., et al., Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension, 2003. 41(6): p. 1202-11.

29. Winkelmann, B. R., et al., Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J, 1999. 137(4 Pt 1): p. 698-705.

30. Sethi, A. A., et al., Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study. Hypertension, 2001. 37(3): p. 875-81.

31. Sethi, A. A., et al., Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med, 2001. 134(10): p. 941-54.

32. Pilbrow, A. P., et al., Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure. Hypertension, 2007. 49(2): p. 322-7.

33. Zafarmand, M. H., et al., The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study. Hypertens Res, 2008. 31(7): p. 1299-305.

34. Medica, I., A. Kastrin, and B. Peterlin, Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol, 2007. 131(2): p. 115-26.

35. Kamitani, A., et al., Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension, 1995. 25(5): p. 950-3.

36. Vasku, A., et al., Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension. Kidney Int, 1998. 53(6): p. 1479-82.

37. Poch, E., et al., Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension, 2001. 38(5): p. 1204-9.

38. Unger, T., The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens, 1999. 17(12 Pt 2): p. 1775-86.

39. Martin, M. M., et al., The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem, 2007. 282(33): p. 24262-9.

40. Abdi, R., et al., Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation, 2001. 72(4): p. 726-9.

41. Bonnardeaux, A., et al., Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension, 1994. 24(1): p. 63-9.

42. Wang, W. Y., R. Y. Zee, and B. J. Morris, Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet, 1997. 51(1): p. 31-4.

43. Hu, Y., Y. Bi, and G. Guan, [The association between A1166-->C of angiotensin II type 1 receptor gene and pregnancy induced hypertension]. Zhonghua Fu Chan Ke Za Zhi, 2000. 35(3): p. 136-8.

44. Osterop, A. P., et al., AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension, 1998. 32(5): p. 825-30.

45. Amant, C., et al., The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol, 1997. 29(3): p. 486-90.

46. Henrion, D., et al., Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro. J Vasc Res, 1998. 35(5): p. 356-62.

47. Kiliszek, M., et al., A1166C polymorphism of the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment. Clin Chem Lab Med, 2007. 45(7): p. 839-42.

48. Saab, Y. B., et al., Renin-angiotensin-system gene polymorphisms and depression. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5): p. 1113-8.

49. Kuznetsova, T., et al., Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation, 2004. 110(17): p. 2644-50.

50. Weber, K. T. and C. G. Brilla, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation, 1991. 83(6): p. 1849-65.

51. Paillard, F., et al., Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension, 1999. 34(3): p. 423-9.

52. Freitas, S. R., et al., Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension. Braz J Med Biol Res, 2007. 40(3): p. 309-16.

53. Casiglia, E., et al., C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens, 2005. 23(11): p. 1991-6.

54. Franco, E., et al., Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet, 2007. 8: p. 27.

55. Yajnik, C. S., et al., Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India. Asia Pac J Clin Nutr, 2007. 16(1): p. 103-9.

56. van der Put, N. M., et al., Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 1995. 346(8982): p. 1070-1.

57. James, S. J., et al., Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr, 1999. 70(4): p. 495-501.

58. Mills, J. L., et al., Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet, 1999. 86(1): p. 71-4.

59. Skibola, C. F., et al., Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A, 1999. 96(22): p. 12810-5.

60. Lucock, M., Is folic acid the ultimate functional food component for disease prevention? BMJ, 2004. 328(7433): p. 211-4.

61. Penney, D. S. and K. G. Miller, Nutritional counseling for vegetarians during pregnancy and lactation. J Midwifery Womens Health, 2008. 53(1): p. 37-44.

62. Catania, J. and D. S. Fairweather, DNA methylation and cellular ageing. Mutat Res, 1991. 256(2-6): p. 283-93.

63. Vanyushin, B. F., et al., The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents. Gerontologia, 1973. 19(3): p. 138-52.

64. Costello, J. F. and C. Plass, Methylation matters. J Med Genet, 2001. 38(5): p. 285-303.

65. Silaste, M. L., et al., Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr, 2001. 131(10): p. 2643-7.

66. Gonzalez-Porras, J. R., et al., Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism. Thrombosis research, 2007. 119(6): p. 691-8.

67. Goodman, C. S., et al., Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol, 2006. 56(4): p. 230-6.

68. Yenicesu, G. I., et al., A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol, 2009. 63(2): p. 126-36.